Phase 3 Readout~month

Phase 3 Topline: An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Sa

Name: Phase 3 Topline: An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Sa
Start: 2028-11-01

November 1, 2028

Company: ALUMIS INC. (ALMS)
Indication: Psoriasis; Plaque Psoriasis; Psoriasis (PsO)

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Phase 3 Topline: An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Sa — ALMS Phase 3 Readout | BioSniper